Fluent

Fluent Stock-Based Compensation

Delisted

The Stock-Based Compensation (SBC) of Fluent (TIUM.U.CN) as of Nov 6, 2026 is 149,000.00 USD. In the previous year, Stock-Based Compensation (SBC) was 219,000.00 USD — a change of -31.96% (lower).

Stock-Based Compensation

149,000.00USD

YoY

-31.96%

Last updated:

Stock-Based Compensation (SBC) of Fluent is 2023 149,000.00 USD. Stock-Based Compensation (SBC) of Fluent was 2022 219,000.00 USD. It decreases by -31.96% lower compared to the previous year.

The Fluent Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2019
3.00 M USD
Jan 1, 2020
1.70 M USD
Jan 1, 2021
1.50 M USD
Jan 1, 2022
219,000.00 USD
Jan 1, 2023
149,000.00 USD
The Fluent Stock-Based Compensation history
YEARStock-Based CompensationYoY
149,000.00USD-31.96%
219,000.00USD-85.41%
1.50 MUSD-11.60%
1.70 MUSD-43.42%
3.00 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Fluent Stock analysis

What does Fluent do? Fluent Corp operates under the private label Fluent, selling medical cannabis products in Florida, Texas, and Pennsylvania. The company's products include oral drops, capsules, suppositories, topicals, syringes, dried flower, pre-rolls, cartridges, edibles, and accessories. Subsidiaries such as Cansortium Holdings LLC and Cansortium Florida, LLC handle production and sales, while Fluent Servicing, LLC manages servicing aspects. The company's revenue comes from direct sales of medical cannabis products through its licensed operations in multiple states. Fluent Corp's target customers are patients seeking medical cannabis treatments, with products tailored to various consumption methods. The company leverages its subsidiaries to maintain compliance and expand its market reach across different states. Sales are conducted through licensed dispensaries and medical cannabis programs, focusing on the healthcare segment of the cannabis industry. The business model relies on the production and sale of medical cannabis under the private label Fluent, utilizing subsidiaries to manage state-specific operations. Products are distributed through established medical cannabis channels, with no mention of additional revenue streams beyond product sales. The company's focus remains on the medical cannabis market, serving patients in Florida, Texas, and Pennsylvania. Fluent is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Fluent stock

Stock-Based Compensation (SBC) of Fluent is 149,000.00 USD in 2023.

Stock-Based Compensation (SBC) of Fluent changed from 219,000.00 USD to 149,000.00 USD, representing a -31.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Fluent since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Fluent historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Fluent

All Key Metrics — Fluent